6-K ·Filed Nov 6, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor the November 24 results release for revenue and EPS against the consensus of $38.2M and $0.01 per ADS, and for any update on the Lyme disease vaccine candidate under FDA review.
VALN drugs
VALN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5Entry
$5.51
T+0 close · Nov 6, 2026 · via day close
Latest settled
+2.72%
T+5 · $5.66
Vs SPY
+0.13%
α at T+5
Next horizon
T+20
in 20d
- T+0 · Nov 6 $5.51entry
- T+1 · 8d ago +2.72%α +0.36% · $5.66
- T+5 · 4d ago +2.72%α +0.13% · $5.66
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
Loading chart...
How similar events traded
Executive Summary
Valneva issued a press release announcing it will report nine-month 2026 financial results on November 24, 2026. The filing contains no financial results, guidance, or material operational updates, it is a routine results-date notice.
Key Facts
- Valneva will report nine-month 2026 financial results on November 24, 2026
- A live webcast will follow at 3 p.m. CET / 9 a.m. ET
- No financial data, guidance, or business updates were provided in this filing
Financial Impact
No financial figures disclosed
Risk Factors
- No financial or operational content in this filing; all material information will come on November 24
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
82% bullish (11 analysts)
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-071423 |
| Document: a2026_11x04x9mxresultsxcur.htm | 0001628280-26-071423 |
| Document: 0001628280-26-071423-index-headers.html | 0001628280-26-071423 |
| Document: 0001628280-26-071423-index.html | 0001628280-26-071423 |
| Document: 0001628280-26-071423.txt | 0001628280-26-071423 |
| Earnings Context (Synthetic; results releases only) | 0001628280-26-071423 |
Track record
9 reports on VALN
Filters
- Nov 13, 20263d ago 6-K Neutral 4/10 Entry $5.66 Now $5.65 −0.18% settles Dec 14
- Nov 6, 202610d ago 6-K Neutral 2/10 Viewing Entry $5.51 Now $5.65 +2.54% settles Dec 7
- Oct 15, 20264w ago 6-K Neutral 2/10 Entry $5.91 to $5.76 Now $5.65 −4.40% ▼ −2.54% −0.64% vs SPY
- Oct 8, 20265w ago 6-K Neutral 3/10 Entry $5.69 to $5.64 Now $5.65 −0.70% ▼ −0.88% +4.41% vs SPY
- Jun 17, 202621w ago EFFECT Neutral 3/10 Entry $5.35 to $5.08 Now $5.65 +5.61% ▼ −5.05% −6.36% vs SPY
- Jun 5, 202623w ago 6-K Neutral 2/10 Entry $5.48 to $5.40 Now $5.65 +3.10% ▼ −1.46% −3.32% vs SPY
- Jun 1, 202624w ago 6-K Neutral 2/10 Entry $5.95 to $5.23 Now $5.65 −5.04% ▼ −12.10% −10.80% vs SPY
- May 5, 202627w ago 6-K Neutral 2/10 Entry $5.29 to $5.63 Now $5.65 +6.81% ▲ +6.43% +1.47% vs SPY
- Mar 26, 202633w ago 6-K Neutral 3/10 Entry $6.32 to $5.50 Now $5.65 −10.60% ▼ −12.97% −23.64% vs SPY
Showing 9 of 9
US Market Status
Market Closed · Opens Wed (10h 19m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers